Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Human Factors

Date Submitted: May 5, 2024
Date Accepted: Dec 1, 2024
Date Submitted to PubMed: Dec 7, 2024

The final, peer-reviewed published version of this preprint can be found here:

Following Up Patients With Chronic Pain Using a Mobile App With a Support Center: Unicenter Prospective Study

Gómez-González MA, Cordero Tous N, De la Cruz Sabido J, Sánchez Corral C, Lechuga Carrasco B, López-Vicente M, Olivares Granados G

Following Up Patients With Chronic Pain Using a Mobile App With a Support Center: Unicenter Prospective Study

JMIR Hum Factors 2025;12:e60160

DOI: 10.2196/60160

PMID: 39644490

PMCID: 11776344

Follow up of patients with chronic pain using a mobile phone app with a support center: unicenter prospective study

  • Marta Antonia Gómez-González; 
  • Nicolas Cordero Tous; 
  • Javier De la Cruz Sabido; 
  • Carlos Sánchez Corral; 
  • Beatriz Lechuga Carrasco; 
  • Marta López-Vicente; 
  • Gonzalo Olivares Granados

ABSTRACT

Background:

Lower back pain is one of the most prevalent diseases, and should be treated with a multidisciplinary approach, being a possibility the use of spinal cord stimulation. These patients need a close follow up that cannot always be guaranteed, with new technologies helping in that regard. We designed a remote follow up system based on a mobile phone app for the patient, a web for professionals, and a remote support center.

Objective:

To evaluate patient adherence to follow up using a system with phone app and a remote support center.

Methods:

After reviewing the literature and approval in a multidisciplinary committee, a group of experts designed a follow up system based on a mobile phone app, a web for professionals and a remote support center. The system was designed with medical professionals involved, sending validated scales to obtain patients’ clinical information through every phase of the implantation (pre-treatment phase, trial phase and implantation phase). Data was collected prospectively from annuary 2020 to august 2023, considering total surveys sent and surveys answered to, in addition to reminders sent.

Results:

A total of 64 patients were included (40 female, 62’5%). At the end of the study, 19 patients were in the pre-treatment phase (29’7%), 8 patients achieved the trial phase (12’5%) and 37 achieved the implantation phase (57’8%). The follow up time was 15’30 +/- 9’43 months (mean +/- SD). A total of 1574 surveys were sent, with a total of 488 sms and 53 calls to remind the patients to answer the surveys. Adherence rates decreased from 94’53% in pre-treatment phase to 65’68% in implantation phase, being the global adherence to the use of the app 87’37%. In the ANOVA analysis, the adherence was proved better the earlier phase the patient was in (p>0’001).

Conclusions:

Our remote follow up system with a remote support center provides better adherence to follow up, even if the adherence tends to decrease over time. More studies are needed to correlate app adherence with pain control.


 Citation

Please cite as:

Gómez-González MA, Cordero Tous N, De la Cruz Sabido J, Sánchez Corral C, Lechuga Carrasco B, López-Vicente M, Olivares Granados G

Following Up Patients With Chronic Pain Using a Mobile App With a Support Center: Unicenter Prospective Study

JMIR Hum Factors 2025;12:e60160

DOI: 10.2196/60160

PMID: 39644490

PMCID: 11776344

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.